NM_000642.3:c.2522C>T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000642.3(AGL):​c.2522C>T​(p.Ser841Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00204 in 1,612,178 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S841Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0023 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 10 hom. )

Consequence

AGL
NM_000642.3 missense

Scores

2
4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 5.68
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010740131).
BP6
Variant 1-99884427-C-T is Benign according to our data. Variant chr1-99884427-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 256727.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00228 (346/151948) while in subpopulation AMR AF= 0.0036 (55/15266). AF 95% confidence interval is 0.00284. There are 2 homozygotes in gnomad4. There are 158 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGLNM_000642.3 linkc.2522C>T p.Ser841Phe missense_variant Exon 19 of 34 ENST00000361915.8 NP_000633.2 P35573-1A0A0S2A4E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGLENST00000361915.8 linkc.2522C>T p.Ser841Phe missense_variant Exon 19 of 34 1 NM_000642.3 ENSP00000355106.3 P35573-1

Frequencies

GnomAD3 genomes
AF:
0.00228
AC:
346
AN:
151830
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000291
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00361
Gnomad ASJ
AF:
0.0141
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.000380
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00271
Gnomad OTH
AF:
0.00671
GnomAD3 exomes
AF:
0.00277
AC:
689
AN:
248886
Hom.:
3
AF XY:
0.00300
AC XY:
405
AN XY:
135100
show subpopulations
Gnomad AFR exome
AF:
0.000257
Gnomad AMR exome
AF:
0.00183
Gnomad ASJ exome
AF:
0.0151
Gnomad EAS exome
AF:
0.0000546
Gnomad SAS exome
AF:
0.00295
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.00307
Gnomad OTH exome
AF:
0.00512
GnomAD4 exome
AF:
0.00201
AC:
2938
AN:
1460230
Hom.:
10
Cov.:
32
AF XY:
0.00217
AC XY:
1576
AN XY:
726484
show subpopulations
Gnomad4 AFR exome
AF:
0.00123
Gnomad4 AMR exome
AF:
0.00199
Gnomad4 ASJ exome
AF:
0.0150
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00326
Gnomad4 FIN exome
AF:
0.000301
Gnomad4 NFE exome
AF:
0.00161
Gnomad4 OTH exome
AF:
0.00365
GnomAD4 genome
AF:
0.00228
AC:
346
AN:
151948
Hom.:
2
Cov.:
32
AF XY:
0.00213
AC XY:
158
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.000314
Gnomad4 AMR
AF:
0.00360
Gnomad4 ASJ
AF:
0.0141
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00353
Gnomad4 FIN
AF:
0.000380
Gnomad4 NFE
AF:
0.00271
Gnomad4 OTH
AF:
0.00664
Alfa
AF:
0.00306
Hom.:
2
Bravo
AF:
0.00221
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00374
AC:
32
ExAC
AF:
0.00276
AC:
335
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00404
EpiControl
AF:
0.00457

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease type III Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 06, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Oct 31, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

AGL: BP4, BS2 -

not specified Benign:1
Mar 02, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Jan 08, 2022
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

AGL-related disorder Benign:1
Aug 24, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T;T;T;T;.
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.97
D;.;.;.;D
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.011
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L;L;L;.
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-2.2
N;N;N;N;N
REVEL
Benign
0.084
Sift
Benign
0.031
D;D;D;D;D
Sift4G
Uncertain
0.051
T;T;T;T;D
Polyphen
0.26
B;B;B;B;B
Vest4
0.28
MVP
0.53
MPC
0.060
ClinPred
0.030
T
GERP RS
5.8
Varity_R
0.46
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150441555; hg19: chr1-100349983; COSMIC: COSV105135400; API